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ABSTRACT: TsTX is an α-type sodium channel toxin that stimulates the discharge of 
neurotransmitters from neurons. In the present study we investigated which 
neurotransmitters are released in the hippocampus after TsTX injection and if they 
are responsible for electrographic or histopathological effects. Microdialysis revealed 
that the toxin increased glutamate extracellular levels in the hippocampus; however, 
levels of gamma-aminobutyric acid (GABA), glycine, 5-hydroxyindoleacetic acid (5-
HIAA), homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) were 
not significantly altered. Neurodegeneration in pyramidal cells of hippocampus and 
electroencephalographic alterations caused by the toxin were blocked by 
pretreatment with riluzole, a glutamate release inhibitor. The present results suggest 
a specific activity of TsTX in the hippocampus which affects only glutamate release.  
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INTRODUCTION 
The toxicity of scorpion venoms is due to neurotoxins that are composed of basic 
polypeptides with molecular weights of approximately 7,000 Da. These toxins affect 
cell permeability to ions including sodium, potassium, chloride and calcium (1-4). 
Sodium channel neurotoxins affect sodium conductance in various excitable tissues, 
thus serving as important pharmacological tools for the study of excitability and 
sodium channel structure (5). 
Scorpion neurotoxins that act on sodium channels have been divided into two 
groups, α and β toxins, according to the ligand-binding sites in the channel. The α-
scorpion toxins were the first to be studied. Their primary effect is interference in 
channel inactivation upon prolonged depolarization, increasing sodium permeability 
and consequently extending the duration of the action potential (6). One of the main 
consequences is the augmented release of neurotransmitters from neuronal endings 
(7). 
Gomez and Diniz (8) were the first to isolate toxic polypeptides from the venom of the 
Brazilian scorpion Tityus serrulatus. According to Arantes et al. (9), TsTX was first 
isolated by Coutinho Netto in 1975. This α-type sodium channel toxin increases the 
release of glutamate, acetylcholine and GABA from different preparations of nervous 
tissue (10-13). When injected in the dorsal hippocampus of rats, it induces behavioral 
alterations and epileptic discharges besides neurodegeneration (14). 
The aim of the present study was to investigate which neurotransmitters are released 
after TsTX intrahippocampal injection. To do this, microdialysis analysis was 
performed to evaluate extracellular levels of some cerebral neurotransmitters.  
In a previous study, we observed an increase in extracellular levels of glutamate only 
until three hours after toxin injection (11). Based on the toxin kinetic and on the 
glutamate release profile observed in that study, we decided to lengthen the time of 
collection (15).  
Moreover, since the previous work by Nencioni et al. (11) had indicated the 
involvement of glutamate in the convulsive/neurodegenerative effect of the toxin; in 
the present study, we examined the result of pretreatment with riluzole (2-amino-6-
trifluoromethoxy benzothiazole, RP54274), a drug that inhibits glutamate release and 
presents neuroprotective, anticonvulsant, anxiolytic and anesthetic properties (16).  
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MATERIALS AND METHODS 
Subjects 
Male Wistar rats (200 to 250 g), obtained from an established colony kept by the 
Central Animal House Service at the Butantan Institute, were used. Upon their arrival 
in the laboratory (seven days before the experiments), the animals were individually 
housed in wire mesh cages and kept at constant temperature (22 ± 1°C), in a 12-
hour light/12-hour dark cycle (lights on at 0700 h), with food and water provided ad 
libitum.  
The animals employed in the current study were maintained in accordance with the 
policies of the Ethics Committee on Use of Laboratory Animals, Butantan Institute, 
Brazil. 
 
TsTX Purification 
Tityus serrulatus toxins were obtained according to the method described by 
Carvalho et al. (14). Briefly, the venom was extracted with 0.05 M ammonium 
bicarbonate buffer, pH 8.0, and eluted in Sephadex® G-50 M (Pharmacia Fine 
Chemicals, USA). Active fractions 30 to 63 (pool IV) were eluted with ammonium 
bicarbonate (0.05 M, pH 8.0) in Sephadex® G-25 M column (Pharmacia Fine 
Chemicals, USA). The peptides purified by gel filtration chromatography were 
separated by high performance liquid chromatography (HPLC) and the peak 8 was 
used (TsTX). 
 
Chemicals 
• Ringer solution (Aster, Brazil)  
• TsTX scorpion toxin (Butantan Institute, Brazil) dissolved in Ringer solution 
• L-glutamic acid HCl (Research Biochemicals International, USA) 
• L-aspartic acid (Research Biochemicals International, USA) 
• Glycine (Sigma, USA) 
• γ-aminobutyric acid (Sigma, USA) 
• Riluzole hydrochloride (Tocris, USA) dissolved in 10% dimethyl sulfoxide 
(DMSO – Sigma, USA) 
• Phenyl isothiocyanate (Sigma, USA) 
• Sodium acetate (Merck, Germany) 
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• Triethylamine (Sigma, USA) 
• Ethylenediaminetetraacetic acid  (EDTA – Merck, Germany) 
• Acetonitrile (Malinkrodt, USA) 
• 3,4-dihydroxybenzylamine (DHBA – Sigma, USA)  
• Perchloric acid (Merck, Germany) 
• Sodium metabisulfit (Merck, Germany) 
 
Surgery 
Rats were anesthetized with an intraperitoneal (IP) injection of 3 mL/kg of a mixture 
of pentobarbitone (1 g) and chloral hydrate (4 g) diluted in 100 mL of 0.9% NaCl. 
Animals were placed in a stereotaxic frame and a microdialysis guide cannula was 
implanted unilaterally in their dorsal hippocampus. Guide cannulas were fixed to the 
skulls with stainless steel jeweler screws and dental acrylate. The guide cannulas for 
microdialysis were implanted in rats according to the following coordinates: 5.3 mm 
posterior to bregma, 3.2 mm lateral to midline, and 2 mm below dura mater (17). The 
cannulas were used for both toxin injection and dialysate collection. In rats 
undergoing behavioral studies and EEG recording, the coordinates were 4.8 mm 
posterior to bregma, 3.2 mm lateral to midline, and 2.8 mm below dura mater. In 
these rats, bipolar twisted electrodes for depth recordings were implanted 
contralaterally at the same coordinates and anchored to the skull as were the 
cannulas. Jeweler screws were inserted bilaterally in the skull over the occipital 
cortex for surface recordings. A screw placed in the frontal sinus was employed as 
reference (indifferent electrode). The surgery was conducted using aseptic 
techniques and animals with surgical complications were excluded. Subsequently, 
rats were individually housed and allowed to recover for one or two days.  
 
Experimental Groups 
A control group of six rats, used for EEG recording and histology, received a 2-µL 
intrahippocampal injection of Ringer solution. A second group composed of 11 rats 
received an intrahippocampal injection of 2 µg of TsTX diluted in 2 µL of Ringer 
solution. These animals were used for microdialysis experiments (five for amino acid 
test and six for analysis of monoamine) and histology. A third group of 11 rats 
received an IP injection of riluzole (5 mg/kg of body weight) and 15 minutes later a 2-
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µg intrahippocampal injection of TsTX. Six rats from this latter group were employed 
for EEG recording and histology, while the remainder were utilized for amino acid 
analysis. 
 
Microdialysis  
Microdialysis was performed in freely-moving rats between 24 and 48 hours after 
implantation of guide cannulas. The probe (CMA/11 microdialysis probe, membrane 
length 2.0 mm – CMA Microdialysis Instruments, Sweden) was introduced into the 
guide cannula of each animal while the inlet was connected through 70-cm 
polyethylene tubing to a 2.5-mL Hamilton® syringe (Hamilton Company, USA). The 
outlet was connected to a 15-cm polyethylene tubing. Ringer solution was perfused 
at a flow rate of 2.13 µL/min and the final volume of samples was approximately 60 
µL. After  30 to 45 minutes of equilibration period, the outflow was collected every 30 
minutes during two hours. Subsequently, the probe was disconnected without flux 
interruption and the toxin was injected through the cannula. After that, the probe was 
connected again to each rat and twelve additional microdialysis samples were 
collected until the end of the experiment. Pretreated animals received an IP injection 
of riluzole 15 minutes before the toxin administration, without disconnecting probes. 
At the end of the collection, samples were dried and frozen (–80°C) until the analysis. 
For biogenic amine determination, samples were collected in a tube with 5.0 μL of a 
solution composed of EDTA, sodium metabisulfite and perchloric acid. 
 
Measurement of Neurotransmitter Concentration 
Extracellular neurotransmitter levels in the dialysate were expressed as μg/μL or 
μg/mL. The first four samples from each animal were used as control and compared 
with post-treatment samples of the same individual. 
Statistical significance was evaluated by one-way repeated measures analysis of 
variance and Tukey’s post-hoc test. Values of p < 0.05 were considered significant. 
 
Monoamines 
Levels of dopamine (DA) and its metabolites (DOPAC and HVA), 5-HT and its 
metabolite (5-HIAA), and norepinephrine (NE) were measured by a HPLC system 
(model 6A, Shimadzu, Japan) with a C-18 Shim pack-ODS® column (Shimadzu, 
Japan), an electrochemical detector (model 6A, Shimadzu, Japan), a sample injector 
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(valve for 20 #1), and an integrator (model 6A Chromatopac®, Shimadzu, Japan). 
Dihydroxybenzylamine (DHBA) was used as the internal standard. The limit of 
detection was 0.002 ng for DA, DOPAC, NE, 5-HT and 5-HIAA, and 0.02 ng for HVA. 
 
Amino Acids 
All samples were analyzed for amino acid content through HPLC along with 
ultraviolet (UV) detection after precolumn phenylisothiocyanate derivatization. The 
mobile phase consisted of solution A (19 g sodium acetate, 0.5 mL triethylamine and 
200 µL of 1 M EDTA; for 470 mL of this solution, 30 mL acetonitrile was added), and 
solution B (400 mL acetonitrile, 100 mL water and 100 µL of 1 M EDTA). The 
gradient profile was determined to clearly identify each amino acid sample by 
comparison with the retention time of an amino acid standard solution containing 1 
mM glutamate, 1 mM γ-aminobutyric acid (GABA) and 1 mM glycine. 
The sample was mixed with 50 µL phenylisothiocyanate, and distilled water was 
added to a 350-µL volume. Levels of glutamate, glycine and GABA from the dialysate 
were determined by means of HPLC with UV detection at 254 nm.  
 
Electroencephalographic Recordings and Behavioral Observations 
Electroencephalographic recordings and behavioral observations were carried out in 
a glass compartment placed in a Faraday cage. Animals were connected to a 
PowerLab® recording apparatus (ADInstruments, Canada) and allowed to settle 
down for 15 minutes. Subsequently, basal electroencephalographic trace was 
recorded for 15 minutes. In rats treated with riluzole, the drug basal trace was 
analyzed for additional 15 minutes after its injection. Afterwards, an intracerebral 
injection of the toxin was administered through a 5 µL Hamilton® microsyringe 
(Hamilton Company, USA) connected with polyethylene tubing to an injection needle. 
Then, EEG was recorded and the behavior was observed for extra four hours.  
 
Histology 
The location of implanted electrodes and guide cannulas was histologically 
examined. Animals that presented missing target areas were excluded. Seven days 
after the injection, animals were completely anesthetized with CO2 and received a 
cardiac perfusion (left ventricle) with phosphate-buffered saline (PBS) solution 
followed by 10% formalin solution. The brains were removed, stored in formalin for at 
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least one week, and embedded in Paraplast® (Oxford Labware, USA). Coronal brain 
sections of 10 µm were cut on microtome from a 700 µm brain block containing the 
cannula track. Every sixth tissue slice was mounted on a glass slide and stained with 
cresyl violet. And the other five slices from each animal had their hippocampal field 
analyzed. The number of cells in the CA1, CA3 and CA4 hippocampal areas was 
examined through a light microscope at 400x magnification. A two-dimensional cell 
counting was performed using a 100 x 100 µm reticulum. Only pyramidal neurons 
located in the area of the reticulum that had a visible nucleus and nucleolus were 
considered intact. ANOVA followed by Tukey’s test were employed for statistical 
analysis (p < 0.05). 
 
RESULTS 
Monoamine Levels 
TsTX did not significantly affect levels of homovanillic acid (HVA), 3,4-
dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) 
(Figure 1). Levels of norepinephrine and its metabolites, serotonin and dopamine 
were not detected by our HPLC. 
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Figure 1. Extracellular levels of hippocampal HVA (a), DOPAC (b) and 5-HIAA (c). 
Levels determined by microdialysis in conscious rats before and after ipsilateral 
intrahippocampal injection of 2 µg TsTX. Arrows indicate time of toxin (T) injection. 
Error bars show standard deviation p < 0.05 compared to pre-injection level, one-way 
repeated measures ANOVA and Tukey’s test. All groups n = 5. 
 
Extracellular Amino Acid Levels 
Injection of TsTX toxin into the hippocampus augmented glutamate concentration in 
extracellular fluid (Figure 2), which reached statistical significance three hours after 
the injection. TsTX did not significantly affect levels of GABA and glycine. 
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Pretreatment with riluzole (5 mg/kg body weight, IP at t = –15 min) prevented TsTX 
effect on hippocampal glutamate level (Figure 2). 
 
 
Figure 2. Extracellular levels of hippocampal glutamate (a), glycine (c), and GABA 
(e) determined by microdialysis in conscious rats before and after ipsilateral 
intrahippocampal injection of 2 µg TsTX. Panels on the right (b, d, f) show the effect 
of pretreatment with riluzole (5 mg/kg IP) on the response to toxin intrahippocampal 
injection. Arrows indicate time of riluzole (R) and toxin (T) injection. Error bars show 
standard deviation p < 0.05 compared to pre-injection level, one-way repeated 
measures ANOVA and Tukey’s test. All groups n = 5.  
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Electroencephalographic Recordings and Behavioral Observations 
Ringer solution injection into CA1 hippocampal area caused no alterations in 
behavior or in electroencephalographic records. Results of TsTX intrahippocampal 
injection were previously described and included long electroencephalographic 
epileptic-like discharges, immobility, orofacial movements and “wet dog shakes” in all 
animals (14). The effects started five to ten minutes after the injection and persisted 
for the entire recording period. 
Rats treated with riluzole or with riluzole and toxin did not show epileptiform activity in 
electroencephalographic records or behavioral signs of convulsion. 
 
Histology 
Injection of Ringer solution into the hippocampus did not influence the number of 
cells in this area neither in the ipsilateral or contralateral regions (Figure 3). 
According to previous descriptions, outcomes provoked by intracerebral injection of 
the toxin were degeneration of pyramidal cells in ipsilateral and contralateral CA1 
regions, and in CA3 and CA4 fields of the ipsilateral hippocampus (11, 14). Many 
dark-stained neurons were observed, which indicated the degeneration. Pretreatment 
with riluzole completely prevented toxin-induced cell loss. The number of cells in the 
ipsilateral and contralateral areas in these animals was similar to the control group 
(Figure 3).  
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Figure 3. Number of cells in the ipsilateral and contralateral CA1, CA3 and CA4 
areas of the hippocampus after intrahippocampal injection of 2 µg TsTX, both in the 
presence and absence of riluzole (5 mg/kg). Rats were killed seven days after the 
inoculation. Error bars indicate standard deviation p < 0.05 compared to control 
group (Ringer) and Tukey’s test. All groups n = 6. 
 
DISCUSSION 
Among scorpion neurotoxins, the α-group is the most studied and the more useful in 
the functional mapping of the sodium channel structure (18). 
TsTX is an α-toxin that acts by enhancing neurotransmitter release in the central and 
peripheral nervous system (19, 20). Some studies have demonstrated that this toxin 
releases glutamate, acetylcholine and adenosine triphosphate (ATP) from rat cortical 
synaptosomes, and GABA and dopamine from cortical slices (10, 13, 21-24). 
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Moreover, in vivo studies reveal that it induces electroencephalographic and 
histopathological alterations (14). 
The present work aimed to assess the profile of in vivo neurotransmitter release in 
the hippocampus after TsTX injection. Based on the toxin kinetics and on the 
glutamate release profile registered in a previous study, in the current study the 
collection period was prolonged up to six hours after the injection and other 
neurotransmitters were analyzed (11, 15). It was observed that the toxin injected into 
the hippocampus did not modify extracellular levels of 5-HIAA, HVA, DOPAC, glycine 
or GABA. Nevertheless, extracellular levels of glutamate were significantly increased. 
These findings agree with Nencioni et al. (11) who observed enhanced levels of 
glutamate for three hours after the toxin injection and no alterations in GABA or 
glycine levels.  
According to Nunan et al. (15), TsTX can be found in rat brain after subcutaneous 
(SC) injections. In adult animals the toxin increase is smaller and slower than in 
young ones. The highest brain concentration of the toxin was observed one hour 
after the inoculation in young rats and three hours later in adult ones, in which the 
levels were augmented up to 12 hours. These results were in accordance with ours, 
which revealed continuous enhancing in glutamate release that persisted until the 
end of the collection and probably after (six hours or more). Moreover, considering 
that in our study the toxin was injected directly into the brain, there was a large 
quantity of glutamate in the hippocampus.  
Similar results had been obtained by Dorce and Sandoval (25) with crude venom, 
when DA, HVA, NE and 5-HIAA levels as well as glutamic acid decarboxylase (GAD) 
activity were determined after intravenous (IV) or intrastriatal injection of Tityus 
serrulatus crude venom. Subsequently, an increase in HVA levels and a decrease in 
GAD activity in the striatum and hypothalamus were observed. On the other hand, no 
alteration was registered in neurotransmitter levels in the hippocampus. 
Previous data provided evidences that glutamate is the main responsible for TsTX 
neurotoxic effects since glutamate receptor antagonists totally or partially block the 
toxin effects (11). This hypothesis was corroborated by the utilization of riluzole, a 
substance that belongs to a class of anticonvulsant and neuroprotective agents 
which selectively inhibits glutamate release over release of other neurotransmitters 
(26, 27). Zona et al. (28) concluded that riluzole modulates Na+ currents and the late 
K+ current in cortical neurons; both phenomena are compatible with the 
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anticonvulsant and neuroprotective properties of this compound. A decrease of the 
voltage-activated Na+ current certainly reduces neuronal excitability and enhances 
excitatory amino acid release (28). Under experimental conditions, the drug 
prevented audiogenic convulsion in DBA/2 mice, maximal electroshock and 
amygdala-kindled seizures in rats, as well as delayed the appearing of seizures and 
reduced the duration of afterdischarges (29, 30). 
Riluzole injection 15 minutes before the toxin inoculation abolished all electrographic 
alterations as well as neuronal losses. Riluzole, when intraperitoneally injected, 
achieves the entire brain, including ipsi and contralateral areas of hippocampus, 
preventing the excitotoxic effects of the toxin. Animals did not show behavioral 
alterations either. They slept throughout the collection period, which is consistent with 
the finding that riluzole easily crosses the blood brain barrier and enhances slow-
wave and rapid eye movement sleep (31). The level of extracellular glutamate 
remained elevated and reached statistical significance in 2 points in rats pretreated 
with riluzole; however, it is not enough to provoke epileptiform activity or neuronal 
loss. 
According to Meldrum (32), enlarged release of glutamate may worsen or prolong 
preexisting seizure activity, while GABA release may be a compensatory inhibitory 
mechanism that limits the progression and spread of seizure activity (33). However, 
hippocampal augmentation of extracellular glutamate and GABA levels are directly 
related to seizure activity rather than to the convulsant agent (34). Meurs et al. (34) 
described that maximal glutamate increases occurred in the early stages of seizure 
development, and preceded maximal GABA elevation. Nevertheless, in our results, 
the electrographic convulsive activity did not keep a relation with the maximal 
extracellular glutamate level. Seizure activity onset occurred (approximately 15 
minutes after toxin injection) before glutamate extracellular level reach a significant 
increase (approximately three hours after the injection), indicating that it is not 
necessary the maximal increase in glutamate extracellular levels to initiate 
convulsions. The convulsive activity enhanced by TsTX is not so intense to increase 
GABA levels. Rats treated with riluzole and TsTX maintained elevated levels of 
glutamate, although, they did not present behavioral or electrographic signs of 
convulsion neither neuronal loss. The glutamate level in these animals was not as 
high as in the group treated only with the toxin. It appears that riluzole can block 
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convulsions and neurotoxicity elicited by TsTX without completely revert this 
increase. 
In hippocampal neurons, voltage-gated sodium channels appear to be the primary, if 
not the only, target responsible for synaptic effects of riluzole at low micromolar 
concentrations. Riluzole’s voltage-dependent blockade of sodium channels enhances 
the depression of excitatory postsynaptic currents, which does not apply to inhibitory 
postsynaptic currents determined by GABA. Inhibition of sodium channels account 
for the preferentially anti-glutamate effect of this drug. Therefore, the preferential 
depression of glutamate release is explained by a direct effect of riluzole on 
glutamatergic cells (35). 
These findings constitute an evidence of a putative specific activity of TsTX, at least 
in the hippocampus, that affects only glutamate release. 
In our opinion, outcomes of TsTX in the hippocampus may be due to its interaction 
with a specific subtype of sodium channel. Different actions on sodium channels 
produce diverse consequences on neurotransmitter release that involve distinct 
presynaptic calcium channels, which supports the idea that sodium channels may 
modulate neurotransmitter release (22). Depending on the rate of increase in channel 
conductance, the outcome in terms of neurotransmitter release and calcium channel 
type coupled to that event is different (36). 
A large number of biological toxins exert their effects by modifying sodium channels 
properties (37). Gilles et al. (38) elucidated, for the first time, how different toxins 
affect mammalian central and peripheral excitable cells. They interact selectively with 
sodium channel subtypes in a discrete subcellular region. The study by Gilles et al. 
(39) revealed unexpected subtype specificity of toxins that interact with receptor site 
3 (α-type toxins). Additionally, it was found that multiple sodium channel subtypes in 
mammalian brain can be pharmacologically distinguished by their sensitivity into 
certain toxins, such as ScαTxs (scorpion α-toxins) and αLTxs (spider α-latrotoxins) 
(39).  
Numerous different isoforms of mammalian voltage-gated sodium channels have 
been identified (37). These multiple subtypes of sodium channels are the products of 
at least six distinct genes that differ in subcellular localization, developmental pattern 
of expression, and abundance in different brain regions (40-48).  
Scorpion α-toxins provide a unique instrument for the identification of sodium channel 
subtypes due to their affinity for different channel subtypes (47). Thus, TsTX may be 
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an important tool to study the functional role and distribution of channel subtypes in 
the hippocampus. 
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